ISR Articles

  1. Outsourced Manufacturing: Comparing Large Vs. Small Molecule 5/22/2018

    Results from a Q42017 ISR survey of 177 biopharmaceutical sponsors asking how the proportion of outsourced manufacturing for large molecule products compare to that of small molecule products.

  2. Outsourcing Success Requires Constant Evolution

    Industry Standard Research explains how Life Science Leader’s CMO Leadership Awards and market research data can help biopharma companies make more informed CMO selection decisions.

  3. Industry Trends In Clinical Development Technology

    As electronic data sources become embedded in the clinical development process, discover how systems, processes, files, storage, and approvals are moving away from paper and becoming dependent on technology applications.

  4. Do Strategic Partnerships Meet Outsourcers Expectations?

    Dive into the learnings from a study on outsourcing model usage, with insights from companies that outsource commercial manufacturing. 

  5. Trends In Bioprocessing CDMO Selection

    Learn which CDMO characteristics experienced outsourcers value most from ISR’s Bioprocessing Market Trends and Outsourcing Dynamics report.

  6. Sponsor Challenges When Outsourcing Sterile Injectables

    Outsourcers of sterile injectable drug product were asked to identify their biggest challenge when outsourcing to CDMOs/CMOs. Here's a look at the resulting nearly four-way tie.

  7. CMOs Continue To Exceed Sponsor Expectations

    ISR explains how the CMO Leadership Awards and the corresponding market research data can be used to make more informed CMO selection decisions and optimize operational and marketing strategies.

  8. COVID-19's Impact On Outsourced Manufacturing

    More than half of the biologic drug product outsourcers surveyed by ISR experienced outsourced manufacturing complications because of the pandemic. To understand how COVID-19 impacted the outsourced manufacturing sector, ISR answered a few questions on the topic in their annual contract development and manufacturing benchmarking studies.

  9. Outsourcers' CMO Preferences

    In Q4, 2019, ISR asked 676 buyers of outsourced manufacturing services about which types of CMOs their organization prefers, large, global CMOs with broad capabilities or Small, niche CMOs with highly specialized capabilities. Respondents’ preference leans towards the big guys. 44% agree-strongly agree that their organization prefers large, global CMOs as compared to 28% who indicate their organization prefers smaller, niche CMOs with specialized capabilities.

  10. Areas Of Growth For Oral-Dose Outsourcing

    The long history and market dominance of oral dosage forms have made this category of drug product a good candidate for outsourced manufacturing. And, according to respondents* who participated in Industry Standard Research’s 2019 Oral Dosage Forms survey, there are no signs of oral-dose outsourcing letting up.